I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 12 studies | 20% ± 5% | |
| endothelial cell | 11 studies | 26% ± 9% | |
| oligodendrocyte precursor cell | 9 studies | 28% ± 13% | |
| oligodendrocyte | 8 studies | 25% ± 7% | |
| natural killer cell | 7 studies | 18% ± 3% | |
| epithelial cell | 7 studies | 31% ± 12% | |
| astrocyte | 7 studies | 29% ± 12% | |
| glutamatergic neuron | 7 studies | 39% ± 22% | |
| microglial cell | 6 studies | 21% ± 5% | |
| connective tissue cell | 6 studies | 24% ± 4% | |
| endothelial cell of lymphatic vessel | 6 studies | 20% ± 2% | |
| interneuron | 6 studies | 33% ± 19% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 19% ± 3% | |
| pericyte | 5 studies | 20% ± 3% | |
| basal cell | 5 studies | 27% ± 7% | |
| smooth muscle cell | 5 studies | 18% ± 3% | |
| GABAergic neuron | 5 studies | 42% ± 12% | |
| ciliated cell | 4 studies | 26% ± 9% | |
| myofibroblast cell | 4 studies | 21% ± 4% | |
| goblet cell | 4 studies | 26% ± 5% | |
| macrophage | 4 studies | 22% ± 5% | |
| mature NK T cell | 3 studies | 16% ± 0% | |
| progenitor cell | 3 studies | 20% ± 3% | |
| amacrine cell | 3 studies | 25% ± 7% | |
| retina horizontal cell | 3 studies | 23% ± 3% | |
| lymphocyte | 3 studies | 21% ± 7% | |
| abnormal cell | 3 studies | 25% ± 5% | |
| regulatory T cell | 3 studies | 19% ± 2% | |
| intestinal crypt stem cell | 3 studies | 15% ± 0% | |
| neuron | 3 studies | 37% ± 6% |
